ECSP077845A - Composiciones y sales dermatológicas para el tratamiento de enfermedades dermatológicas - Google Patents

Composiciones y sales dermatológicas para el tratamiento de enfermedades dermatológicas

Info

Publication number
ECSP077845A
ECSP077845A EC2007007845A ECSP077845A ECSP077845A EC SP077845 A ECSP077845 A EC SP077845A EC 2007007845 A EC2007007845 A EC 2007007845A EC SP077845 A ECSP077845 A EC SP077845A EC SP077845 A ECSP077845 A EC SP077845A
Authority
EC
Ecuador
Prior art keywords
dermatological
treatment
salts
compositions
diseases
Prior art date
Application number
EC2007007845A
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Astion Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astion Pharma As filed Critical Astion Pharma As
Publication of ECSP077845A publication Critical patent/ECSP077845A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composiciones dermatológicas de oxaprozina o un compuesto estrechamente relacionado adecuado adaptado para el tratamiento de una enfermedad dermatológica, donde al menos dos de las enzimas seleccionadas entre la proteína tirosina quinasa Syk, la proteína tirosina quinasa ZAP-70 y la fosfodiesterasa IV cumplen una función en una enfermedad dermatológica. La invención también abarca composiciones dermatológicas para el tratamiento de prurito.
EC2007007845A 2005-03-30 2007-10-29 Composiciones y sales dermatológicas para el tratamiento de enfermedades dermatológicas ECSP077845A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DKPA200500437 2005-03-30
DKPA200500438 2005-03-30
US69477405P 2005-06-27 2005-06-27
DKPA200500948 2005-06-27
DKPA200500949 2005-06-27
US69504005P 2005-06-28 2005-06-28

Publications (1)

Publication Number Publication Date
ECSP077845A true ECSP077845A (es) 2008-02-20

Family

ID=36215671

Family Applications (3)

Application Number Title Priority Date Filing Date
EC2007007845A ECSP077845A (es) 2005-03-30 2007-10-29 Composiciones y sales dermatológicas para el tratamiento de enfermedades dermatológicas
EC2007007843A ECSP077843A (es) 2005-03-30 2007-10-29 Tratamiento o prevención del prurito
EC2007007846A ECSP077846A (es) 2005-03-30 2007-10-29 Tratamiento de eczemas

Family Applications After (2)

Application Number Title Priority Date Filing Date
EC2007007843A ECSP077843A (es) 2005-03-30 2007-10-29 Tratamiento o prevención del prurito
EC2007007846A ECSP077846A (es) 2005-03-30 2007-10-29 Tratamiento de eczemas

Country Status (12)

Country Link
EP (3) EP1707200A1 (es)
JP (3) JP2008534527A (es)
KR (3) KR20080005526A (es)
AU (3) AU2006228869A1 (es)
BR (3) BRPI0609653A2 (es)
CA (3) CA2603297A1 (es)
EA (3) EA200702026A1 (es)
EC (3) ECSP077845A (es)
IL (3) IL186022A0 (es)
MX (3) MX2007012050A (es)
NO (3) NO20075199L (es)
WO (3) WO2006102899A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0821537D0 (en) * 2008-11-25 2008-12-31 Union Life Sciences Ltd Therapeutic target
US20190046481A1 (en) * 2015-09-18 2019-02-14 Delivra Inc. Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions
EP3827793A1 (en) 2016-08-08 2021-06-02 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
JP7199096B2 (ja) 2016-10-25 2023-01-05 ティキュア リミテッド 皮膚疾患における治療標的としてのｆａｂｐ４
CN111683641A (zh) * 2017-12-07 2020-09-18 德玛万科学有限公司 Pde-4抑制剂的局部用软膏剂制剂及其在治疗皮肤病况中的应用
RU2685436C1 (ru) * 2018-06-22 2019-04-18 ЗАО "ФармФирма "Сотекс" Трансдермальный препарат для лечения и профилактики болезней суставов и мягких тканей

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32084B1 (en) 1967-06-07 1973-04-04 Wyeth John & Brother Ltd Thiazole derivatives
US3578671A (en) 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
US4659728A (en) 1985-02-25 1987-04-21 American Home Products Corporation Hydroxy substituted 4,5-diphenyl-2-oxazole propanoic acid
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US6090834A (en) 1993-05-21 2000-07-18 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
JPH09504018A (ja) 1993-10-20 1997-04-22 ザ ブーツ カンパニー ピーエルシー 抗掻痒薬としてのイブプロフェンおよびフルルビプロフェン
JPH07316075A (ja) 1994-05-26 1995-12-05 Pola Chem Ind Inc 皮膚外用剤
GB9606429D0 (en) 1996-03-27 1996-06-05 Boots Co Plc Pharmaceutical compositions
ATE299699T1 (de) * 1996-05-20 2005-08-15 Searle Llc Arzneimittel enthaltend oxaprozin natriumsalz, kaliumsalz, oder tris(hydroxymethyl)aminomethansalz
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
IL142037A0 (en) 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
US20050014729A1 (en) 2003-07-16 2005-01-20 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050232957A1 (en) 2004-04-14 2005-10-20 Katz Kenneth A Compositions and methods for moisturizing skin

Also Published As

Publication number Publication date
CA2603300A1 (en) 2006-10-05
IL186020A0 (en) 2008-01-20
BRPI0609535A2 (pt) 2010-04-13
JP2008534528A (ja) 2008-08-28
NO20075227L (no) 2007-12-09
WO2006102899A2 (en) 2006-10-05
AU2006228870A1 (en) 2006-10-05
EP1707200A1 (en) 2006-10-04
AU2006228871A1 (en) 2006-10-05
ECSP077843A (es) 2008-02-20
JP2008534527A (ja) 2008-08-28
WO2006102900A1 (en) 2006-10-05
ECSP077846A (es) 2008-02-20
CA2605121A1 (en) 2006-10-05
WO2006102898A3 (en) 2006-12-28
EA200702023A1 (ru) 2008-04-28
WO2006102898A2 (en) 2006-10-05
CA2603297A1 (en) 2006-10-05
IL186022A0 (en) 2008-02-09
MX2007012051A (es) 2008-02-22
EA200702027A1 (ru) 2008-02-28
BRPI0609653A2 (pt) 2010-04-20
JP2008534526A (ja) 2008-08-28
EP1707201A1 (en) 2006-10-04
EP1707199A1 (en) 2006-10-04
KR20080005526A (ko) 2008-01-14
IL186021A0 (en) 2008-02-09
WO2006102899A3 (en) 2006-12-28
NO20075218L (no) 2007-12-27
AU2006228869A1 (en) 2006-10-05
EA200702026A1 (ru) 2008-04-28
KR20080005525A (ko) 2008-01-14
NO20075199L (no) 2008-01-02
KR20080011280A (ko) 2008-02-01
BRPI0607648A2 (pt) 2009-09-22
MX2007012052A (es) 2008-02-22
MX2007012050A (es) 2008-03-11

Similar Documents

Publication Publication Date Title
EA200970575A1 (ru) Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения
NO20082476L (no) Bicykliske forbindelser med kinaseinhiberende aktivitet
NO20074431L (no) Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer
CR7043A (es) Derivados de eteres utiles como ganetes inhibidores de las isozimas pde4
NO20071320L (no) Pyrazolsubstituerte aminoheteroarylforbindelser som protein kinase inhibitorer.
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
ATE432281T1 (de) Pyrrolotriazin-kinasehemmer
ECSP099414A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteína quinasa
UA85559C2 (en) Aminobenzophenone compounds
WO2007079199A3 (en) Substituted bis-amide metalloprotease inhibitors
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
WO2009006389A8 (en) Pyrimidine derivatives useful as raf kinase inhibitors
EA200800172A1 (ru) 2,4-диаминопиримидины как ингибиторы aurora
EA200800727A1 (ru) Введение ингибиторов дипептидилпептидазы
GEP20115283B (en) Pyrrolopyrimidine compounds and their uses
ATE548363T1 (de) 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
DK1789398T3 (da) 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE)
ECSP077985A (es) Inhibidores de proteina cinasa derivados de pirrol (2,3-b) piridina
NO20076502L (no) Pyrrolopyridiner nyttige som inhibitorer av proteinkinase
CL2007001749A1 (es) Compuesto derivado de 2-arilamino-4-(heterociclo)aminopirimidina, inhibidores de la proteina quinasa c-alfa; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de diabetes, cancer, enfermedad cardiaca coronaria, aterosclerosis, entre otras.
NZ594385A (en) Aminopyrimidines useful as kinase inhibitors
NO20071915L (no) Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer
BRPI0512547A (pt) pirimidinas
ATE542814T1 (de) Pyrazinkinaseinhibitoren
EA200800546A1 (ru) Бензимидазолтиофеновые соединения в качестве ингибиторов polo-подобных киназ (plk)